Last Price
344.07
Today's Change
-3.83 (1.10%)
Day's Change
339.09 - 347.50
Trading Volume
198,893
Market Cap
10 Billion
Shares Outstanding
31 Million
Avg Volume
287,341
Avg Price (50 Days)
340.85
Avg Price (200 Days)
368.64
PE Ratio
30.13
EPS
11.42
Earnings Announcement
10-Feb-2025
Previous Close
347.90
Open
347.50
Day's Range
339.09 - 347.5
Year Range
286.755 - 459.77
Trading Volume
203,292
1 Day Change
-1.10%
5 Day Change
1.37%
1 Month Change
0.34%
3 Month Change
4.19%
6 Month Change
-9.80%
Ytd Change
2.78%
1 Year Change
15.40%
3 Year Change
107.28%
5 Year Change
292.42%
10 Year Change
1138.11%
Max Change
1138.11%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.